Ischemic Optic Neuropathy
11
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
18%
2 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
New Non-invasive Modalities for Assessing Retinal Structure and Function
Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery
Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair
Ischemic Optic Neuropathy Decompression Trial (IONDT)
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)